Adjust Text Size:
Browse Clinical Trials
Join the Email List
Sign up for our email bulletin
Participant Stories
“I participate because it is the right thing to do, for myself, for my children, and for the millions of people who have Parkinson’s disease. Without participation there will be no cure.” –Mike, Diagnosed 7 years
Recently Diagnosed with Parkinson's Disease?
If you have recently been diagnosed with Parkinson’s disease (PD) understanding the disease, and learning about the resources available to you, are good first steps.
Study of Rasagiline as Add-on to Dopamine Agonists in the Treatment of Parkinson’s Disease
Official Study Title: Double-blind, Double-blindClinical study design in which neither investigators nor participants know who is receiving the investigational drug and who is receiving a placebo. Placebo PlaceboAn inactive substance or procedure (often a pill, liquid, or powder) that has no biological effect. In clinical trials, experimental treatments are often compared with placebos to assess the treatment's effectiveness. In some studies, the participants will be assigned to a control group and will receive a placebo instead of an active drug or treatment. Controlled, Randomized, Multicenter Study to Assess the Safety and Clinical ClinicalDealing with or based on observation and treatment of people, as opposed to basic science carried out in the laboratory or in animals. Benefit of Rasagiline as an Add on Theapy to Stable Dose of Dopamine DopamineA "chemical messenger" that regulates movement by assisting in the effective communication (transmission) of electrochemical signals in the brain from one nerve cell (neuron) to another. As dopamine producing cells degenerate with advancing PD, they no longer produce enough to regulate neurons elsewhere in the brain, resulting in a loss of control of movements, leading to symptoms such as slowed movements, tremor, and rigidity. Agonists in the Treatment of Early Parkinson's Disease
Sponsor: Teva Neuroscience, Inc.
Clinicaltrials.gov ID: NCT01049984
Study ID: TVP-1012/PM103
Summary
Dopamine agonists are increasingly used as first-line therapy TherapyAnother word for “treatment”. for those who are newly diagnosed with Parkinson’s disease (PD). As the disease progresses, dopamine agonists alone do not fully control the symptoms of PD and additional dopaminergic therapy is needed.
Participants will be enrolled in the study at the screening/ ScreeningPeriod of selection of clinical trial participants based on ELIGIBILITY CRITERIA. baseline BaselinBeginning measurements against which a participant’s progress can be quantified at the end of a study. visit based on need for additional PD symptom control despite dopamine agonist Dopamine AgonistA chemical or drug that mimics the role of dopamine in the brain. treatment and will be dispensed rasagiline or matching placebo for the following objectives:
- To assess the efficacy EfficacyThe extent to which a specific intervention, procedure, or regimen produces a beneficial result under ideal conditions. of rasagiline as add-on treatment to dopamine agonist therapy in people with early PD not optimally treated on dopamine agonists.
- To investigate whether rasagiline influences the adverse effects of the dopamine agonists.
- To characterize the efficacy of rasagiline on reducing disability, including non-motor symptoms. Non-Motor SymptomsContribute to severe disability and impaired quality of life in advanced Parkinson's disease. Symptoms include anxiety, depression, cognitive mood swings, dementia, constipation, pain, genitourinary problems, sudden drop in blood pressure upon standing (orthostatic hypotension), excessive sweating, and sleep disturbances, sense of smell, vision, memory, weight loss, psychosis, hallucinations, and loss of energy.
Study Phase
Phase 4
What is a study phase?
Symptoms Addressed: Movement and Non-movement
Balance, Diminished sense of smell, Freeze Attacks, Freeze AttacksThe sudden loss of ability to move. General PD symptoms, Loss of Motor Skills, Masked Face, Masked FaceLoss of facial expression and reduced blink rate and eye movement make a person appear to be staring off in the distance, which can be misinterpreted as lack of interest or depression. Postural difficulties, Rigidity, RigidityA symptom in which muscles feel stiff and display resistance to movement even when another person tries to move the affected part of the body. Sleep disturbances, Slowness of movement (bradykinesia) BradykinesiaSlowness of movement. , Tremor, TremorShaking or rhythmic movement, especially in the hands but in other parts of the body. Often occurs when at rest, such as in the RESTING TREMOR. Uncontrollable movements (Dyskinesia) DyskinesiaTwisting, turning or other abnormal involuntary movement usually involving the arms, legs, trunk, and head. It is most commonly associated with long-term use of levodopa. , Walking/Gait GaitWay of walking, which is diminished in people with Parkinson’s who tend to shuffle their feet, take too short steps, and not swing one or both arms.
Time Commitment
- Less than six months
- 3 visits at 9 week intervals
Eligibility
- Minimum Age: 30
- Gender(s) Accepted: Either
Inclusion Criteria
- Participants receiving a stable dose of oral ropinirole or pramipexole whose symptoms are not optimally controlled or whose oral dopamine agonist treatment regimen was stopped due to intolerability.
- Dopamine agonist treatment must have been ongoing for 30 days or longer, but no longer than five years preceding the baseline visit.
- Women of childbearing potential must agree to practice an acceptable method of birth control.
- Diagnosis of Parkinson’s disease. Disease confirmed at screening/baseline by the presence of at least two of the cardinal signs (resting tremor, Resting TremorA tremor of a limb that increases when the limb is at rest. bradykinesia, rigidity), without other known or suspected cause of Parkinsonism.
- Dopamine agonist dose must be stable for 30 days or longer preceding the baseline visit.
- For participants who are receiving amantadine or anticholinergics, the dose must have been stable for 30 days or longer prior to screening.
- Participants must be willing and able to give written informed consent Informed ConsentThe process of providing information to potential study participants to help them decide whether or not to enroll in a specific clinical trial. prior to performing any study procedures.
Exclusion Criteria
- People receiving rasagiline or any other MAO inhibitor within 60 days preceding the baseline visit.
- People receiving levodopa LevodopaA compound that is converted into dopamine (the brain chemical which is deficient in people with Parkinson's) in the brain. for more than 21 consecutive days within 90 days prior to the baseline visit.
- People experiencing moderate to severe motor fluctuations.
- People with hepatic impairment (a liver defect, in the investigator’s judgment).
- Any investigational medications within 30 days preceding the baseline visit.
- Dopamine agonist use at least 5 years prior to baseline,
- People with major depression, significant cognitive CognitiveRelated to mental activities having to do with perception, memory, judgment, and reasoning. impairment or an impulse control disorder (ICD)
- Pregnant or lactating women or women planning to become pregnant within the next 18 weeks.
- People with uncontrolled hypertension (high blood pressure). Hypertensive people whose BP is controlled with study parameters are eligible.
- Concomitant MAO inhibitors or medications contraindicated for use with MAO inhibitors are not allowed. Disallowed medications include: Meperidine, Dextromethorphan, Tramadol, St. John’s wort, Methadone, Propoxyphene, Cyclobenzaprine, Cocaine, Ciprofloxacin or other CYP1A2 inhibitors.
Enrollment
Expected Enrollment: 360 (US)
Date Enrollment Began: Dec 2009
Date Enrollment Ends: Jan 2011
Last Updated Date: Sep 13 2010
Trial Post Date: Mar 04 2010
Website: http://www.researchforpd.com
Primary Contacts and Locations
All States
- Central Call Number
Phone: (800) 887-8100
All States
USA
Local Contacts and Locations
Arizona
- Arshia Sadreddin, M.D., Investigator — Edie Simpson, Study Coordinator
Barrow Neurology NeurologyThe scientific study of the nervous system, especially in respect to its structure, functions, and abnormalities. Clinics
edie.simpson@chw.edu
Phone: (602) 406-6259
240 West Thomas Street
Suite #301
Phoenix, AZ 85013
USA - Holly Shill, M.D., Investigator — Beth Karoll, Study Coordinator
Sun Health Research Institute
beth.karoll@bannerhealth.org
Phone: (623) 875-6500
10515 W. Santa Fe Drive
Sun City, AZ 85351
USA
California
- Perminder Bhatia, M.D., Investigator — Raj Brar, Study Coordinator
Neuro Pain Medical Center
raj.brar@sbcglobal.net
Phone: (559) 437-9700
736 E. Bullard Avenue Suite #101
Fresno, CA 93710
USA - Robert Hutchman, M.D., Investigator — Wayne Pickerell, Study Coordinator
Neurosearch, Inc.
wayne.pickerell@neurosearch-usa.com
Phone: (818) 332-7986, EXT. #712
19231 Victory Blvd.
Suite #355
Reseda, CA 91335
USA - Grace Liang, M.D., Investigator — Liza Infeld, Study Coordinator
The Parkinson's Institute
linfel@parkinsonsinstitute.org
Phone: (408) 542-5626
675 Almanor Avenue
Sunnyvale, CA 94085
USA - David Margolin, M.D., Ph.D., Investigator — Tamanjit Basi, Study Coordinator
Margolin Brain Institute
dimmd@sbcglobal.net
Phone: (559) 299-1515
1515 E. Alluvial Avenue
Suite #101
Fresno, CA 93720
USA - Robert Shorr, M.D., Investigator — Wayne Pickerell, Study Coordinator
Neurosearch II, Inc.
wayne.pickerell@neurosearch-usa.com
Phone: (805) 715-1041
2781 Loma Vista Road
Suite C/D
Ventura, CA 93003
USA - Dee Silver, M.D., Investigator — Sonia Casillas, Study Coordinator
Coastal Neurological Medical Group, Inc.
sonia_coastal@hotmail.com
Phone: (858) 453-3842, EXT. #15
9850 Genesee Avenue, #740
La Jolla, CA 92307
USA - Daniel Truong, M.D. — Investigator
The Parkinson's and Movement Disorder Institute
9940 Talbert Avenue
Suite #204
Fountain Valley, CA 92708
USA - Dao Vo — Study Coordinator
The Parkinson's and Movement Disorder Institute
dvo@pmdi.org
Phone: (714) 378-5062
9940 Talbert Avenue
Suite #204
Fountain Valley, CA 92708
USA - Michelle Tran — Study Coordinator
The Parkinson's and Movement Disorder Institute
mtran@pmdi.org
Phone: (714) 378-5062
9940 Talbert Avenue
Suite #204
Fountain Valley, CA 92708
USA
Connecticut
- J. Antonelle DeMarcaida, M.D. — Investigator
Eastern Connecticut Neurology Specialists, L.L.C.
394 West Center Street
Manchester, CT 06040
USA - Sheila Thurlow — Study Coordinator
East Connecticut Neurology Specialists, L.L.C
thurlow@uchu.edy
Phone: (860) 647-7831
394 West Center Street
Manchester, CT 06040
USA - Elizabeth Perotti — Study Coordinator
Associated Neurologists of Southern CT, P.C.
eperrotti@anscneuro.com
Phone: (203) 333-1151
75 Kings Highway Cutoff
Fairfield, CT 06824
USA - Kenneth Siegel, M.D. — Investigator
Associated Neurologists of Southern CT, P.C.
75 Kings Highway Cutoff
Fairfield, CT 06824
USA
Delaware
- Kathleen Greenbaum — Study Coordinator
Christiana Care Neurology Specialists
kgreenbaum@christianacare.org
Phone: (302) 623-3844
4735 Ogletown-Stanton Road
Suite #3203
Newark, DE 19713
USA - Lanny Edelsohn, M.D. — Investigator
Christiana Care Neurology Specialists
4735 Ogletown-Stanton Road
Suite #3203
Newark, DE 19713
USA
Florida
- Ajay Arora, M.D. — Investigator
Morton Plant Neuroscience Clinic
Morton Plant Street Suite 402
Clearwater, FL 33756
USA - Vickie Lindemann — Study Coordinator
Morton Plant Neuroscience Clinic
s0nnyside@aol.com
Phone: (727) 492-7378
Morton Plant Street Suite 402
Clearwater, FL 33756
USA - Claudia Lennertz — Study Coordinator
Collier Neurologic Specialists
clennertz@collierneurologic.com
Phone: (239) 434-0332
730 Goodlette Road Suite #100A
Naples, FL 34102
USA - John Campbell, M.D. — Investigator
Collier Neurologic Specialists
730 Goodlette Road Suite #100A
Naples, FL 34102
USA - Lisa Fagin — Study Coordinator
Collier Neurologic Specialists
lfagin@collierneurologic.com
Phone: (239) 434-0332
730 Goodlette Road Suite #100A
Naples, FL 34102
USA - Holly Delgado — Study Coordinator
University of South Florida
hdelgado@health.usf.edu
Phone: (813) 844-4453
5 Tampa General Circle
Suite #410
Tampa, FL 33606
USA - Robert Hauser, M.D. — Investigator
University of South Florida
5 Tampa General Circle
Suite #410
Tampa, FL 33606
USA - Nayara Chagas — Study Coordinator
Parkinson's Disease Parkinson's DiseaseA chronic, slowly progressive disease of the nervous system characterized by the combination of tremor, rigidity, bradykinesia and stooped posture, among other symptoms. and Movement Disorder Center of Boca Raton
nchagas@parkinsonscenter.org
Phone: (561) 392-1818, EXT. #6
951 NW 13th Street
Building #5E
Boca Raton, FL 33486
USA - Stuart Issacson, M.D. — Investigator
Parkinson's Disease and Movement Disorders Center of Boca Raton
951 NW 13th Street
Building #5E
Boca Raton, FL 33486
USA - Sheila Roby — Study Coordinator
Bradenton Research Center
sheilaroby@bradentonresearch.com
Phone: (942)708-0005, EXT. #18
3924 9th Avenue West
Bradenton, FL 34205
USA - William McElveen, M.D. — Investigator
Bradenton Research Center
3924 9th Avenue West
Bradenton, FL 34205
USA - James S. Schafer, M.D., Investigator — Vickie Bussey, Study Coordinator
Vero Beach Neurology
vbussey@geodysseyrsch.com
1155 35th Lane
Suite 100
Vero Beach, FL 32960
USA
Georgia
- Beverly Johnson-Finley — Study Coordinator
Neurology Specialists of Decatur
beverly.finley@dekalbmedical.org
Phone: (404) 501-7566
2665 N. Decatur Road
Suite #630
Decatur, GA 30033
USA - Michael Norman, M.D. — Investigator
Neurology Specialists of Decatur
2665 N. Decatur Road
Suite #630
Decatur, GA 30033
USA
Iowa
- Jen Anderson — Study Coordinator
Iowa Health Physicians
andersjl5@ihs.org
Phone: (515) 241-4200
1221 Pleasant Street
Suite #300
Des Moines, IA 50309
USA - Lynn Struck, M.D. — Investigator
Iowa Health Physicians
1221 Pleasant Street
Suite #300
Des Moines, IA 50309
USA
Idaho
- Jane Harris — Study Coordinator
The Movement Disorders Center at the Elks
jmharris@elksrebah.org
Phone: (208) 489-4599
600 N. Robbins Road
Boise, ID 83702
USA - Lauren Seeberger, M.D. — Investigator
The Movement Disorders Center at the Elks
600 N. Robbins Road
Boise, ID 83702
USA
Illinois
- Laura Reckamp — Study Coordinator
Glenbrook Department of Neurology
Phone: (847) 570-5845
2100 Pfingsten Road
Suite #3000
Glenview, IL 60026
USA - Arif Dalvi, M.D.
Glenbrook Department of Neurology
2100 Pfingsten Road
Suite #3000
Glenview, IL 60026
USA
Indiana
- Jo Belden — Study Coordinator
Indiana University
jbelden@iupui.edu
Phone: (317) 274-3989
550 University Blvd.
Room #5595
Indianapolis, IN 46202
USA - Joanne Wojcieszek, M.D. — Investigator
Indiana University
550 University Blvd.
Room #5595
Indianapolis, IN 46202
USA
Kentucky
- Laura Sanders — Study Coordinator
Associates in Neurology, P.S.C.
laurasanders@ainlex.com
Phone: (859) 296-1922
1021 Majestic Drive Suite #200
Lexington, KY 40513
USA - Shelley O'Brien — Study Coordinator
Associates in Neurology, P.S.C.
sobrien@ainlex.com
Phone: (859) 296-1922
1021 Majestic Drive Suite #200
Lexington, KY 40513
USA - Warren Chumley, M.D. — Investigator
Associates in Neurology, P.S.C.
1021 Majestic Drive Suite #200
Lexington, KY 40513
USA - Sunni Mauk, M.D. — Study Coordinator
Innovative Clinical Concepts
smauk@iccresearch.com
Phone: (270) 448-5154
3121 Parisa Drive
Paducah, KY 42003
USA - William Hogancamp, M.D. — Investigator
Innovative Clinical Concepts
3121 Parisa Drive
Paducah, KY 42003
USA
Massachusetts
- Ellen Gill — Study Coordinator
South Shore Neurology
egill@southshoreneurology.com
Phone: (781) 331-4923
851 Main Street Suite #11
Weymouth, MA 02190
USA - Paul Blachman, M.D. — Investigator
South Shore Neurology
851 Main Street Suite #11
Weymouth, MA 02190
USA - Carin Nelson — Study Coordinator
Springfield Neurology Associates
carinanelson@verizon.net
Phone: (413) 781-5045
300 Carew Street
Suite #2
Springfield, MA 01104
USA - Michael Rossen, M.D. — Investigator
Springfield Neurology Associates
300 Carew Street
Suite #2
Springfield, MA 01104
USA
Maryland
- Bryan Walker — Study Coordinator
Bay Area Neurology, L.L.C.
bryan.walker@mac.com
Phone: (410) 266-2740
2002 Medical Parkway Suite #430
Annapolis, MD 21401
USA - Larry Blum, M.D. — Investigator
Bay Area Neurology, L.L.C.
2002 Medical Parkway Suite #430
Annapolis, MD 21401
USA
Maine
- Edward Drasby, D.O. — Investigator
Port City Neurology
7 Portland Farms Road
Scarborough, ME 04074
USA - Meg Lannon — Clinical Coordinator
Port City Neurology
neclinicaltrials@aol.com
Phone: (207) 885-1400
7 Portland Farms Road
Scarborough, ME 04074
USA
Michigan
- Bridget Patterson — Study Coordinator
Michigan Neurology
bpatterson@michiganneurology.com
Phone: (313) 343-3346
25100 Kelly Road
Roseville, MI 48066
USA - Lynne Froehlich — Study Coordinator
Michigan Neurology
lynne.froelich@stjohn.org
Phone: (313) 343-3346
25100 Kelly Road
Roseville, MI 48066
USA - Paul Cullis, M.D. — Investigator
Michigan Neurology
25100 Kelly Road
Roseville, MI 48066
USA - Margaret McNammee — Study Coordinator
Clinical Neuroscience Center
margaret.mcnamee@yahoo.com
Phone: (248) 355-2452
26400 W. Twelve Mile Road
Suite #115
Southfield, MI 48034
USA - Peter LeWitt, M.D. — Investigator
Clinical Neuroscience Center
26400 W. Twelve Mile Road
Suite #115
Southfield, MI 48034
USA
Minnesota
- Patricia Ede — Study Coordinator
Struthers Parkinson's Center
edepk@parknicollet.com
Phone: (952) 993-5495
6701 Country Club Drive
Golden Valley, MN 55427
USA - Sotirios Parashos, M.D. — Investigator
Struthers Parkinson's Center
6701 Country Club Drive
Golden Valley, MN 55427
USA
Missouri
- Eve Holzemer — Study Coordinator
Saint Louis University School of Medicine
holzemem@slu.edu
Phone: (314) 977-4871
Department of Neurology and Psychiatry
1438 South Grand Blvd.
St. Louis, MO 63104
USA - Jewel Carter — Study Coordinator
Saint Louis University School of Medicine
carterjk@slu.edu
Phone: (314) 977-4871
Department of Neurology and Psychiatry
1438 South Grand Blvd.
St. Louis, MO 63104
USA - Pratap Chand, M.D. — Investigator
Saint Louis University School of Medicine
Department of Neurology and Psychiatry
1438 South Grand Blvd.
St. Louis, MO 63104
USA
Montana
- Connie Winner — Study Coordinator
Great Falls Clinic, L.L.P.
connie.winner@gfclinic.com
Phone: (406) 268-3920
1400 29th Street South
Clinical Research Clinical ResearchPatient-oriented research conducted with human participants (or on material of human origin such as tissues and specimens) for which an investigator directly interacts with human participants. This area of research includes: mechanisms of human disease, therapeutic interventions, clinical trials, or development of new technologies. Department
Great Falls, MT 59405
USA - Eilad Culcea, M.D. — Investigator
Great Falls Clinic, L.L.P.
1400 29th Street South
Clinical Research Department
Great Falls, MT 59405
USA - Jody Gonzales — Study Coordinator
Great Falls Clinic, L.L.P.
jody.gonzales@gfclinic.com
Phone: (406) 268-3920
1400 29th Street South
Clinical Research Department
Great Falls, MT 59405
USA - John Schaeffer, D.O., Investigator — Kathe Swanson, Study Coordinator
Montana Neuroscience Institute Foundation
katheswanson@saintpatrick.org
500 West Broadway
Missoula, MT 59802
USA
North Carolina
- Keisha Fuller — Study Coordinator
Raleigh Neurology Associates
kfuller@raleighneurology.com
Phone: (919) 782-3456, EXT. #8254
1540 Sunday Drive
Raleigh, NC 27607
USA - Keith Hull, M.D. — Investigator
Raleigh Neurological Associates
1540 Sunday Drive
Raleigh, NC 27607
USA - James Patton, M.D. — Investigator
Asheville Neurology Specialists, P.A.
1200 Ridgefield Blvd.
Suite #250
Asheville, NC 28806
USA - Susan Woodward — Study Coordinator
Asheville Neurology Specialists, P.A.
research@ashneuro.com
Phone: (828) 210-9311
1200 Ridgefield Blvd.
Suite #250
Asheville, NC 28806
USA - Sanjay Iyer, M.D., Investigator — Jackie Foster, L.P.N., C.R.C., Study Coordinator
Neuroscience & Spine Institute
Jacqueline.foster@carolinashealthcare.org
1010 Edgehill Road North
Charlotte, NC 28207
USA
North Dakota
- Molly Byrne — Study Coordinator
MeritCare Neuroscience
molly.byrne@meritcare.com
Phone: (701) 234-4104
700 1st Avenue South
Fargo, ND 58103
USA - Tanya Harlow, M.D. — Investigator
MeritCare Neuroscience
700 1st Avenue South
Fargo, ND 58103
USA
New Jersey
- Chinal Patel — Study Coordinator
Princeton and Rutgers Neurology, P.A.
chnchn241@aol.com
Phone: (732) 246-1311
51 Veronica Avenue
Sommerset, NJ 08873
USA - Roger Behar, M.D. — Investigator
Princeton and Rutgers Neurology, P.A.
51 Veronica Avenue
Sommerset, NJ 08873
USA
Nevada
- Eric Farbman, M.D., Investigator — Margie Hyderkhan, Study Coordinator
University of Nevada School of Medicine Division of Neurology
mshyderkhan@medicine.nevada.edu
1707 W. Charleston Ave.
Suite 200
Las Vegas, NV 89102
USA
New York
- Barbara Changizi, M.D. — Investigator
Albany Medical Center
Department of Neurology
47 New Scotland Avenue
Albany, NY 12208
USA - Mary Eglow — Study Coordinator
Albany Medical Center
eglowm@mail.amc.edu
Phone: (518) 262-6651
Department of Neurology
47 New Scotland Avenue
Albany, NY 12208
USA - David Kreitzman, M.D. — Investigator
David L. Kreitzman, M.D., P.C.
283 Commack Road
Suite #101
Commack, NY 11725
USA - Nancy Gardella — Study Coordinator
David L. Kreitzman, M.D., P.C.
researchli@parkinsonscenter.org
Phone: (631) 462-7774
283 Commack Road
Suite #101
Commack, NY 11725
USA - Stephen Newman, M.D. — Investigator
The Comprehensive MS Care Center at Island Neurological Associates
824 Old Country Road
Plainview, NY 11803
USA - Tiffany Harding — Study Coordinator
The Comprehensive MS Care Center at Island Neurological Associates
tiffanyharding@aol.com
Phone: (516) 822-2230, EXT. #131
824 Old Country Road
Plainview, NY 11803
USA
Ohio
- Brian Maddux, M.D. — Investigator
Riverhills Healthcare, Inc.
111 Wellington Place
Cincinnati, OH 45219
USA - Jennifer Palmer — Study Coordinator
Riverhills Healthcare, Inc.
palmer@rhihealth.com
Phone: (513) 241-2370
111 Wellington Place
Cincinnati, OH 45219
USA
Oregon
- Kari Jaasko — Study Coordinator
Medford Neurological and Spine Clinic
research@medfordneuro.com
Phone: (541) 779-1672
2900 State Street
Medford, OR 97504
USA - Walter Carlini, M.D. — Investigator
Medford Neurological and Spine Clinic
2900 State Street
Medford, OR 97504
USA - Richard Rosenblum — Investigator
The Providence Center for Parkinson's Disease
5050 Northeast Hoyt
Suite #315
Portland, OR 97213
USA - Summer Carter — Study Coordinator
The Providence Center for Parkinson's Disease
summer.carter@providence.org
Phone: (503) 216-1034
5050 Northeast Hoyt
Suite #315
Portland, OR 97213
USA
Pennsylvania
- Randie Gollomp — Study Coordinator
Lankenay Hosptial
randie.gollomp@gmail.com
Phone: (610) 642-5371
100 Lancaster Avenue
Suite #161 Lankenau Medical Building East
Wynnewood, PA 19096
USA - Stephen Gollomp, M.D. — Investigator
Lakenau Hospital
100 Lancaster Avenue
Suite #161 Lankenau Medical Building East
Wynnewood, PA 19096
USA
Texas
- Eric Pappert, M.D. — Investigator
Neurology Associates, P.A.
255 East Sonterra Blvd.
Suite #211
San Antonio, TX 78258
USA - Jeff Martinez — Study Coordinator
Neurology Associates, P.A.
jmresearch16@yahoo.com
Phone: (210) 656-2333
255 East Sonterra Blvd.
Suite #211
San Antonio, TX 78258
USA
Virginia
- Alan Schulman, M.D. — Investigator
Neurological Associates, Inc.
7301 Forest Avenue
Suite #300
Richmond, VA 23226
USA - Tamika Walthour — Neurological Associates, Inc.
Study Coordinator
twalthour@NAIRichmond.com
Phone: (804) 282-1154 ext. 3053
7301 Forest Avenue
Suite #300
Richmond, VA 23226
USA - Karen Thomas, D.O. — Investigator
Sentara Medical Group Neurology Specialists
1950 Glenn Mitchell Drive
Suite #200
Virginia Beach, VA 23456
USA - Kim Downey — Study Coordinator
Santara Medical Group Neurology Specialists
lmsharbe@sentara.com
Phone: (757) 388-6134
1950 Glenn Mitchell Drive
Suite #200
Virginia Beach, VA 23456
USA
Washington
- Beena Gangadharan — Study Coordinator
Swedish Neuroscience Institute
beena.gangadharan@swedish.org
Phone: (206) 320-2633
550 17th Avenue
Suite #540
Seattle, WA 98122
USA - Susie Ro, M.D. — Investigator
Swedish Neuroscience Institute
550 17th Avenue
Suite #540
Seattle, WA 98122
USA
Wisconsin
- Merle Teetzen, M.D. — Investigator
Aurora Medical Group
2845 Greenbriar Road
Neurology Suite #140
Green Bay, WI 54308
USA - Theresa Schuck — Study Coordinator
Aurora Medical Group
theresa.shuck@aurorabaycare.com
Phone: (920) 288-3128
2845 Greenbriar Road
Neurology Suite #140
Green Bay, WI 54308
USA
West Virginia
- Ellen Bush — Study Coordinator
Capitol Neurology
ellen.bush47@gmail.com
Phone: (304) 342-3891
415 Morris Street
Suite #100
Charleston, WV 25301
USA - Kiren Kresa-Reahl, M.D. — Investigator
Capitol Neurology
415 Morris Street
Suite #100
Charleston, WV 25301
USA
